A patient-reported, non-interventional, cross-sectional discrete choice experiment to determine treatment attribute preferences in treatment-na？ve overactive bladder patients in the US

Many pharmacotherapeutic treatment options are available for the symptoms of overactive bladder (OAB), each offering varying efficacy, safety, and tolerability profiles that must be carefully considered when selecting treatment. The objective of the present study was to characterize pharmacotherapy treatment preferences of individuals with symptoms of OAB and to examine how preferences differ by both patient characteristics and disease burden metrics